Occupational Asthma and Challenges in Classifying Chemical Respiratory Allergens

Main Article Content

Mark A Pembertona Stuart Hindle Andreas Flueckiger Knut Kreuzer

Abstract

Respiratory Sensitisation is a serious health condition that can have life-threatening consequences and that is regulated under the UN globally harmonised system (GHS) and the European system for classification, labelling and packaging of hazardous chemicals and mixtures (CLP). In the absence of widely accepted and validated approaches for the prospective identification of chemicals that induce respiratory sensitisation, classification relies on clinical evidence of causation of substance-specific respiratory hypersensitivity, typically seen as occupational asthma. Significant advances have been made in recent years in the phenotyping of both asthma and occupational asthma since the introduction of criteria and guidance for classification that are not reflected in the current criteria and guidance. Typically generated clinical data, including specific inhalation challenge tests, while sufficient for diagnosis and health management are often deficient for regulatory classification purposes as they are often not sufficiently documented to meet the required standards and fail to reliably distinguish between occupational asthma and non-specific irritant exacerbation of pre-existing asthma that is regulated under another classification endpoint. A multistakeholder forum is proposed to facilitate revision of the now outdated criteria and guidance. Differences between underlying mechanisms of respiratory sensitisation and occupational asthma jeopardise establishment of an Adverse Outcome Pathway for respiratory sensitisation and development of alternative methods, including non-animal methods.

Keywords: Respiratory Sensitisation, Occupational Asthma, Work Exacerbated Asthma, Clinical Data, Specific Inhalation Challenge (SIC) tests, Classification, Labelling and Packaging (CLP), Globally Harmonised System of Classification and Labelling of Chemicals (GHS)

Article Details

How to Cite
PEMBERTONA, Mark A et al. Occupational Asthma and Challenges in Classifying Chemical Respiratory Allergens. Medical Research Archives, [S.l.], v. 13, n. 8, aug. 2025. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/6794>. Date accessed: 06 dec. 2025. doi: https://doi.org/10.18103/mra.v13i8.6794.
Section
Review Articles

References

1 Hargitai R, Parráková L, Szatmári T, Monfort-Lanzas P, Galbiati V, Audouze K, Jornod F, Staal YCM, Burla S, Chary A, Gutleb AC, Lumniczky K, Vandebriel RJ, Gostner JM. Chemical respiratory sensitization-Current status of mechanistic understanding, knowledge gaps and possible identification methods of sensitizers. Front Toxicol. 2024 Jul 29;6:1331803. doi: 10.3389/ftox.2024.1 331803. PMID: 39135743; PMCID: PMC11317441.

2 UN. Globally Harmonized System of Classification and Labelling of Chemicals. 2023. GHS Rev. 10. The United Nations Economic Commission for Europe, Geneva, Switzerland. Available at https://unece.org/transport/dangerous-goods/ghs-rev10-2023. Accessed on 16th May 2025.

3 EC. Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45 /EC, and amending Regulation (EC) No 1907/2006 (Text with EEA relevance). 2008. Available at http://data.europa.eu/eli/reg/2008/1272/oj

4 McLendon K, Sternard BT. Anaphylaxis. [Updated 2023 Jan 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482124/

5 EC. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/ EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/ EEC, 93/105/EC and 2000/21/EC. 2006. Available at EUR-Lex - 02006R1907-20241010 - EN - EUR-Lex

6 ECHA. Identification of substances as SVHCs due to equivalent level of concern to CMRs (Article 57(f)) – sensitisers as an example. 2012. Available at: https://echa.europa.eu/documents/10162/13657/svhc_art_57f_sensitisers_en.pdf/a50728cc-6514-486c-9108-193a88b4bc9e

7 Pemberton MA, Arts JH, Kimber I. Identification of true chemical respiratory allergens: Current status, limitations and recommendations. Regul Toxicol Pharmacol. 2024 Feb;147:105568. doi: 10.1016/j.yrtph.2024.105568. Epub 2024 Jan 14. PMID: 38228280.

8 Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014 Feb 13;370(7):640-9. doi: 10.1056/NEJMra1301758. PMID: 24521110.

9 Vandenplas O, Wiszniewska M, Raulf M, de Blay F, Gerth van Wijk R, Moscato G, Nemery B, Pala G, Quirce S, Sastre J, Schlünssen V, Sigsgaard T, Siracusa A, Tarlo SM, van Kampen V, Zock JP, Walusiak-Skorupa J; European Academy of Allergy and Clinical Immunology. EAACI position paper: irritant-induced asthma. Allergy. 2014 Sep;69(9):11 41-53. doi: 10.1111/all.12448. Epub 2014 Jul 5. PMID: 24854136.

10 Vandenplas O, Suojalehto H, Cullinan P. Diagnosing occupational asthma. Clin Exp Allergy. 2017 Jan;47(1):6-18. doi: 10.1111/cea.12858. PMI D: 27883240.

11 Malo JL. The case for confirming occupational asthma: why, how much, how far? J Allergy Clin Immunol. 1993 May;91(5):967-70. doi: 10.1016/00 91-6749(93)90207-v. PMID: 8491945.

12 Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, Harber P, Lemiere C, Liss GM, Pacheco KA, Redlich CA, Rowe B, Heitzer J. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest. 2008 Sep;134(3 Suppl):1S-41S. doi: 10.1378/chest.08-0201. Erratum in: Chest. 2008 Oct;134(4):892. PMID: 18779187.

13 Cartier A, Sastre J. Clinical assessment of occupational asthma and its differential diagnosis. Immunol Allergy Clin North Am. 2011 Nov;31(4): 717-28, vi. doi: 10.1016/j.iac.2011.07.005. PMID: 21978853.

14 Tiotiu AI, Novakova S, Labor M, Emelyanov A, Mihaicuta S, Novakova P, Nedeva D. Progress in Occupational Asthma. Int J Environ Res Public Health. 2020 Jun 24;17(12):4553. doi: 10.3390/ijer ph17124553. PMID: 32599814; PMCID: PMC7345155.

15 Moscato G, Pala G, Barnig C, De Blay F, Del Giacco SR, Folletti I, Heffler E, Maestrelli P, Pauli G, Perfetti L, Quirce S, Sastre J, Siracusa A, Walusiak-Skorupa J, van Wjik RG; European Academy of Allergy and Clinical Immunology. EAACI consensus statement for investigation of work-related asthma in non-specialized centres. Allergy. 2012 Apr;67(4): 491-501. doi: 10.1111/j.1398-9995.2011.02784.x. Epub 2012 Jan 19. PMID: 22257175.

16 Pemberton MA, Kimber I. Accurate regulatory classification of chemical respiratory allergens: The case for robust characterisation of causation. Regul Toxicol Pharmacol. 2025 Mar;157:105785. doi: 10.1016/j.yrtph.2025.105785. Epub 2025 Feb 12. PMID: 39952546.

17 Jarjour NN, Kelly EA. Pathogenesis of asthma. Med Clin North Am. 2002 Sep;86(5):925-36. doi: 10.1016/s0025-7125(02)00087-1. PMID: 12428538.

18 Holgate ST. Pathogenesis of asthma. Clin Exp Allergy. 2008 Jun;38(6):872-97. doi: 10.1111/j.136 5-2222.2008.02971.x. PMID: 18498538.

19 Carr TF, Sharma S. Characterizing severe asthma phenotypes. UpToDate.com Literature review current through: Dec 2024. This topic last updated: Jan 10, 2025. Accessed February 2 2025. Available at https://www.uptodate.com/contents/characterizing-severe-asthma-phenotypes

20 Schatz M, Rosenwasser L. The allergic asthma phenotype. J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):645-8; quiz 649. doi: 10.1016/j.jaip. 2014.09.004. Epub 2014 Nov 6. PMID: 25439351.

21 Pembrey L, Barreto ML, Douwes J, Cooper P, Henderson J, Mpairwe H, Ardura-Garcia C, Chico M, Brooks C, Cruz AA, Elliott AM, Figueiredo CA, Langan SM, Nassanga B, Ring S, Rodrigues L, Pearce N. Understanding asthma phenotypes: the World Asthma Phenotypes (WASP) international collaboration. ERJ Open Res. 2018 Aug 22;4(3):00 013-2018. doi: 10.1183/23120541.00013-2018. PMID: 30151371; PMCID: PMC6104297.

22 Kuruvilla ME, Lee FE, Lee GB. Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease. Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233. doi: 10.1007/s12016-018-8712 -1. PMID: 30206782; PMCID: PMC6411459.

23 Bourdin A, Brusselle G, Couillard S, Fajt ML, Heaney LG, Israel E, McDowell PJ, Menzies-Gow A, Martin N, Mitchell PD, Petousi N, Quirce S, Schleich F, Pavord ID. Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma Biologics. J Allergy Clin Immunol Pract. 2024 Apr;1 2(4):809-823. doi: 10.1016/j.jaip.2024.01.023. Epu b 2024 Jan 25. PMID: 38280454.

24 AAAAI. The American Academy of Allergy, Asthma & Immunology. 2024. 555 East Wells Street, Suite 1100, Milwaukee, WI 53202-3823, USA. Available at https://www.aaaai.org/. Accessed 1 Jan 2025.

25 WHO. World Health Organisation factsheet on asthma: global, regional and national incidences, prevalence and years lived with disability for 328 diseases and injuries for 195 countries 190-2016: a systematic analysis for the Global Burden of Disease Study. Lancet, 2016; 390, 1211-1259.

26 Mattiuzzi C, Lippi G. Worldwide asthma epidemiology: insights from the Global Health Data Exchange database. Int Forum Allergy Rhinol. 2020 Jan;10(1):75-80. doi: 10.1002/alr.22464. Epub 2019 Oct 23. PMID: 31645084.

27 Balmes J, Becklake M, Blanc P, Henneberger P, Kreiss K, Mapp C, Milton D, Schwartz D, Toren K, Viegi G; Environmental and Occupational Health Assembly, American Thoracic Society. American Thoracic Society Statement: Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003 Mar 1;167(5):787-97. doi: 10.1164/rccm.167.5.787. PMID: 12598220.

28 Torén K, Blanc PD. Asthma caused by occupational exposures is common - a systematic analysis of estimates of the population-attributable fraction. BMC Pulm Med. 2009 Jan 29;9:7. doi: 10.1186/1471-2466-9-7. PMID: 19178702; PMCID: PMC2642762.

29 Blanc PD, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, Murgia N, Naidoo RN, Reynolds CJ, Sigsgaard T, Torén K, Vinnikov D, Redlich CA. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1312-1334. doi: 10.1164/rccm. 201904-0717ST. PMID: 31149852; PMCID: PMC6543721.

30 Siracusa A, Folletti I, Gerth van Wijk R, Jeebhay MF, Moscato G, Quirce S, Raulf M, Ruëff F, Walusiak-Skorupa J, Whitaker P, Tarlo SM. Occupational anaphylaxis--an EAACI task force consensus statement. Allergy. 2015 Feb;70(2):141-52. doi: 10.1111/all.12541. PMID: 25369880.

31 Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. Eur Respir J. 2003 Oct;22(4):689-97. doi: 10.1183/090 31936.03.00053203. PMID: 14582924.

32 Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med (Lond). 2008 May;58(3):169-74. doi: 10.1093/occmed/kqn007. Epub 2008 Feb 27. PMID: 18308695.

33 Kenyon NJ, Morrisey BM, Schivo M, Albertson TE. Occupational asthma. Clin. Rev. Allergy Immunol. 2012;43, 3-13. DOI: 10.1007/s12016-011-8272-0

34 Lemière C, Boulet LP, Chaboillez S, Forget A, Chiry S, Villeneuve H, Prince P, Maghni K, Kennedy WA, Blais L. Work-exacerbated asthma and occupational asthma: do they really differ? J Allergy Clin Immunol. 2013 Mar;131(3):704-10. doi: 10.1016/j.jaci.2012.08.024. Epub 2012 Oct 8. PMID: 23058644.

35 Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am. J. Respir. Crit. Care Med. 2005;172, 280-305. DOI: 10.1164/rccm.200311-1575SO.

36 Feary J, Pinnock H, Cullinan P. Occupational asthma. Br. Med. J. 2016;353, i2658. DOI: 10.1136/bmj.i2658

37 Friedman-Jimenez G, Harrison D, Luo H. Occupational asthma and work-exacerbated asthma. Seminars in respiratory and critical care medicine. 2015;36(3), 388–407. DOI: 10.1055/s-0035-1550157

38 Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Walusiak-Skorupa J, Munoz X, Sastre J, Klusackova P, Moore V, Merget R, Talini D, Kirkeleit J, Mason P, Folletti I, Cullinan P, Moscato G, Quirce S, Hoyle J, Sherson D, Kauppi P, Preisser A, Meyer N, de Blay F; European network for the PHenotyping of OCcupational ASthma (E-PHOCAS) investigators. Severe Occupational Asthma: Insights From a Multicenter European Cohort. J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2309-2318.e4. doi: 10.1016/j.jaip.2019.03 .017. Epub 2019 Mar 23. PMID: 30914232.

39 Alif SM, Benke G, Kromhout H, Abramson MJ, Kogevinas M, Jarvis D, Le Moual N, Dharmage S, Schlünssen V, Torén K, Norback D, Lytras T, Carsin AE, Svanes C, Olivieri M, Dorado-Arenas S, Urrutia I, Pascual Erquicia S, Acke S, Bentouhami H, Wieslander G, Murgia N, Martínez-Moratalla J, Leynaert B, Radon K, Gerlich J, Nowak D, Villani S, Holm M, Verlato G, D'Errico A, Bakke P, Skorge TD, Storaas T, Dahlman-Höglund A, Hellgren J, Miedinger D, Sigsgaard T, Blanc PD, Zock JP. Occupational exposures and incidence of asthma over two decades in the European Community Respiratory Health Survey. Thorax. 2025 Apr 29:thorax-2024-222307. doi: 10.1136/thorax-2024 -222307. Epub ahead of print. PMID: 40306950.

40 Lemiere C, Chaboillez S, Welman M, Maghni K. Outcome of occupational asthma after removal from exposure: A follow-up study. Can Respir J. 2010 Mar-Apr;17(2):61-6. doi: 10.1155/2010/509 807. PMID: 20422061; PMCID: PMC2866225.

41 Holsapple MP, Jones D, Kawabata TT, Kimber I, Sarlo K, Selgrade MK, Shah J, Woolhiser MR. Assessing the potential to induce respiratory hypersensitivity. Toxicol Sci. 2006 May;91(1):4-13. doi: 10.1093/toxsci/kfj074. Epub 2005 Dec 9. PMID: 16339788.

42 Kimber I, Agius R, Basketter DA, Corsini E, Cullinan P, Dearman RJ, Gimenez-Arnau E, Greenwell L, Hartung T, Kuper F, Maestrelli P, Roggen E, Rovida C; European Centre for the Validation of Alternative Methods. Chemical respiratory allergy: opportunities for hazard identification and characterisation. The report and recommendations of ECVAM workshop 60. Altern Lab Anim. 2007 May;35(2):243-65. doi: 10.1177/02 6119290703500212. PMID: 17559314.

43 Boverhof DR, Billington R, Gollapudi BB, Hotchkiss JA, Krieger SM, Poole A, Wiescinski CM, Woolhiser MR. Respiratory sensitization and allergy: current research approaches and needs. Toxicol Appl Pharmacol. 2008 Jan 1;226(1):1-13. doi: 10.1016/j.taap.2007.10.008. Epub 2007 Oct 22. PMID: 18023833.

44 North CM, Ezendam J, Hotchkiss JA, Maier C, Aoyama K, Enoch S, Goetz A, Graham C, Kimber I, Karjalainen A, Pauluhn J, Roggen EL, Selgrade M, Tarlo SM, Chen CL. Developing a framework for assessing chemical respiratory sensitization: A workshop report. Regul Toxicol Pharmacol. 2016 Oct;80:295-309. doi: 10.1016/j.yrtph.2016.06.006. Epub 2016 Jul 7. PMID: 27396307.

45 Chary A, Hennen J, Klein SG, Serchi T, Gutleb AC, Blömeke B. Respiratory sensitization: toxicological point of view on the available assays. Arch Toxicol. 2018 Feb;92(2):803-822. doi: 10.1007/s00204-017-2088-5. Epub 2017 Oct 16. PMID: 29038838.

46 Arts J. How to assess respiratory sensitization of low molecular weight chemicals? Int J Hyg Environ Health. 2020 Apr;225:113469. doi: 10.1016/j.ijheh. 2020.113469. Epub 2020 Feb 12. PMID: 32058937.

47 Scheel J, Krutz NL, Rajagopal R, Sadekar N, Hindle S, Hickey C, Campbell C, Botham P. Use and limitations of clinical data in the identification and classification of low molecular weight chemicals (LMWCs) as respiratory sensitizers: recommendations for improvement. Crit Rev Toxicol. 2025 Jan;55(1): 27-54. doi: 10.1080/10408444.2024.2433222. Epu b 2025 Jan 9. PMID: 39785825.

48 Tarlo SM, Liss GM. Occupational asthma: an approach to diagnosis and management. CMAJ. 2003 Apr 1;168(7):867-71. Erratum in: CMAJ. 2003 Apr 15;168(8):966. PMID: 12668547; PMCID: PMC151995.

49 Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005 May;62(5):290-9. doi: 10.1136/oem.2004.016287. PMID: 15837849; PMCID: PMC1741012.

50 Nicholson PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C. Evidence based guidelines for the prevention, identification, and management of occupational asthma. Occup Environ Med. 2005 May;62(5):290-9. doi: 10.1136/oem.2004.016287. PMID: 15837849; PMCID: PMC1741012.

51 Aasen TB, Burge PS, Henneberger PK, Schlünssen V, Baur X; ERS Task Force on the Management of Work-related Asthma; EOM Society. Diagnostic approach in cases with suspected work-related asthma. J Occup Med Toxicol. 2013 Jun 14;8(1):17. doi: 10.1186/1745-6673-8-17. PMI D: 23768266; PMCID: PMC3716794.

52 Tarlo SM. The role and interpretation of specific inhalation challenges in the diagnosis of occupational asthma. Can Respir J. 2015 Nov-Dec;22(6):322-3. doi: 10.1155/2015/591010. PMID : 26641806; PMCID: PMC4676394.

53 Preisser, A,M, Koschelm, D, Merget, R, Nowak, D, Raulf, M, Heidrich, J. Workplace-related inhalation test - Specific inhalation challenge: S2k Guideline of the German Society for Occupational and Environmental Medicine e.V. (DGAUM), the German Society for Pneumology and Respiratory Medicine e.V. (DGP) and the German Society for Allergology and Clinical Immunology e.V. (DGAKI). Allergol Select. 2021;315-334. doi: 10.5414/ALX 02280E. PMID: 34646977; PMCID: PMC8507414

54 Baur X, Sigsgaard T, Aasen TB, Burge PS, Heederik D, Henneberger P, Maestrelli P, Rooyackers J, Schlünssen V, Vandenplas O, Wilken D; ERS Task Force on the Management of Work-related Asthma. Guidelines for the management of work-related asthma. Eur Respir J. 2012 Mar;39(3): 529-45. doi: 10.1183/09031936.00096111. Erratum in: Eur Respir J. 2012 Jun;39(6):1553. PMID: 22379148.

55 Johanson G. Are asthmatics more sensitive to irritants? Int J Hyg Environ Health. 2020 May;22 6:113488. doi: 10.1016/j.ijheh.2020.113488. Epub 2020 Feb 20. PMID: 32088597.

56 Pemberton MA, Schmitt B, Hindle S, Flueckiger A, Kreuzer K. The role of exposure determinations in the exclusion of non-specific irritation from Specific Inhalation Challenge Tests. 2025. Submitted to Regulatory Toxicology and Pharmacology.

57 Pemberton MA, Kimber I. Classification of chemicals as respiratory allergens based on human data: Requirements and practical considerations. Regul Toxicol Pharmacol. 2021 Jul;123:104925. doi: 10.1016/j.yrtph.2021.104925. Epub 2021 Apr 5. PMID: 33831493.

58 Chhabra SK, Ojha UC. Late asthmatic response in exercise-induced asthma. Ann Allergy Asthma Immunol. 1998 Apr;80(4):323-7. doi: 10.1016/S1081-1206(10)62977-8. PMID: 9564982.

59 Koh YY, Jeong JH, Jin SM, Kim CK, Min KU. The occurrence of late asthmatic response to exercise after allergen challenge. Ann Allergy Asthma Immunol. 1998 Oct;81(4):366-72. doi: 10.1016/S1081-1206(10)63130-4. PMID: 9809502.

60 ECHA. Guidance on the Application of the CLP Criteria. Part 3: Health Hazards Guidance to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures Version 5.0. 2024. Available at https://echa.europa.eu/documents/10162/2324906/clp_part3_en.pdf/42e0397a-73f2-0583-958f-3830928e1604?t=1730718832043

61 ECHA (European Chemicals Agency), Guidance on the application of the CLP Criteria – Guidance to Regulation (EC) No 1272/2008 on classification, labelling and packaging (CLP) of substances and mixtures. Part 3, Health hazards, European Chemicals Agency, 2024, Available at https://data.europa.eu/doi/10.2823/9350054

62 Pemberton MA, Kimber I. Methyl methacrylate and respiratory sensitisation: a comprehensive review. Crit Rev Toxicol. 2022 Feb;52(2):139-166. doi: 10.1080/10408444.2022.2064267. Epub 2022 May 24. PMID: 35607993.

63 Pemberton MA, Kreuzer K, Kimber I. Challenges in the classification of chemical respiratory allergens based on human data: Case studies of 2-hydroxyethylmethacrylate (HEMA) and 2-hydroxypropylmethacrylate (HPMA). Regul Toxicol Pharmacol. 2023 Jun;141:105404. doi: 10.1016/j.yrt ph.2023.105404. Epub 2023 Apr 26. PMID: 37105297